Research and experimental development on natural sciences and engineering
AURA BIOPHARM AS
Operating profit
NOK −135,000
Equity
NOK −885,000
Incorporated
2016
Share capital
NOK 300,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 135k | |
| Operating profit (EBIT) | −135k | |
| Net financial items | −99 | |
| Profit for the year | −135k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 41k | |
| of which current assets | 41k | |
| Equity | −885k | |
| Total liabilities | 925k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.